Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice

Journal of Neuroscience

Volumn 31, Issue 16, 2011, Pages 6028-6040

  Liu, Meng ^a,e   Blanco Centurion, Carlos ^a   Konadhode, Rodarani ^a,e   Begum, Suraiya ^a   Pelluru, Dheeraj ^a,e   Gerashchenko, Dmitry ^a   Sakurai, Takeshi ^b   Yanagisawa, Masashi ^c   van den Pol, Anthony N ^d   Shiromani, Priyattam J ^a,e  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 3; MELANIN CONCENTRATING HORMONE; OREXIN; OREXIN A; PARVOVIRUS VECTOR; PEPTIDE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; GENE TRANSFER; HUMAN; HUMAN CELL; INNERVATION; LATERAL HYPOTHALAMUS; LOCUS CERULEUS; MOUSE; MUSCLE TONE; NARCOLEPSY; NERVE CELL; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SECRETION; RAT; SLEEP WAKING CYCLE; VIRAL GENE DELIVERY SYSTEM; ZONA INCERTA;

ANIMALS; CATAPLEXY; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENOTYPE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; NARCOLEPSY; NEURONS; NEUROPEPTIDES; SLEEP; SUBTHALAMUS;

EID: 79955780626     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6069-10.2011     Document Type: Article

References (40)

1. Aldrich MS (1993) The neurobiology of narcolepsy-cataplexy. Prog Neurobiol 41:533-541.
2. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE (1992) The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319:218-245.
3. Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM (2005) Narp immu-nostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology 65:1189-1192.
4. Carter ME, Yizhar O, Chikahisa S, Nguyen H, Adamantidis A, Nishino S, Deisseroth K, de Lecea L (2010) Tuning arousal with optoge-netic modulation of locus coeruleus neurons. NatNeurosci 13:1526-1533.
5. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-451.
6. Crocker A, España RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, Honda M, Mignot E, Scammell TE (2005) Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65:1184-1188.
7. Deadwyler SA, Porrino L, Siegel JM, Hampson RE (2007) Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhu-man primates. JNeurosci 27:14239-14247.
8. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neu-roexcitatory activity. Proc Natl Acad Sci USA 95:322-327.
9. Fischer DF, Hol EM, Hobo B, van Leeuwen FW (2006) Alzheimer-associated APP+1 transgenic mice: frameshift beta-amyloid precursor protein is secreted in cerebrospinal fluid without inducing neuropathology. Neurobiol Aging 27:1445-1450.
10. Gulyani S, Wu MF, Nienhuis R, John J, Siegel JM (2002) Cataplexy-related neurons in the amygdala of the narcoleptic dog. Neuroscience 112:355-365.
11. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30:345-354.
12. Hassani OK, Lee MG, Jones BE (2009) Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc Natl Acad Sci USA 106:2418-2422.
13. John J, Wu MF, Boehmer LN, Siegel JM (2004) Cataplexy-active neurons in the hypothala-mus: implications for the role of histamine in sleep and waking behavior. Neuron 42:619-634.
14. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ (2007) Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369:2097-2105.
15. Koyama Y, Takahashi K, Kodama T, Kayama Y (2003) State-dependent activity of neurons in the perifornical hypothalamic area during sleep and waking. Neuroscience 119:1209-1219.
16. Krueger JM, Majde JA, Obal F (2003) Sleep in host defense. Brain Behav Immun 17 [Suppl 1]:S41-S47.
17. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376.
18. Liu M, Thankachan S, Kaur S, Begum S, Blanco-Centurion C, Sakurai T, Yanagisawa M, Neve R, Shiromani PJ (2008) Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci 28:1382-1393.
19. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK (2001) Differential expressionoforexin receptors1and 2in the rat brain. J Comp Neurol 435:6-25.
20. Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M (2004) Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA 101:4649-4654.
21. Mignot E (1998) Genetic and familial aspects of narcolepsy. Neurology 50:S16-S22.
22. Mueller C, Flotte TR (2008) Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 15:858-863.
23. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39-40.
24. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015.
25. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padi-garu M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucher-lapati R, et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence ofhypocretin peptidesinhuman narcoleptic brains. Nat Med 6:991-997.
26. Plaha P, Ben-Shlomo Y, Patel NK, Gill SS (2006) Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 129:1732-1747.
27. Plaha P, Khan S, Gill SS (2008) Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry 79:504-513.
28. Sagar SM, Sharp FR, Curran T (1988) Expression of c-Fos protein in brain: metabolic mapping at the cellular level. Science 240:1328-1331.
29. Saito Y, Cheng M, Leslie FM, Civelli O (2001) Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol 435:26-40.
30. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:1.
31. Scammell TE, Willie JT, Guilleminault C, Siegel JM (2009) A consensus definition of cataplexy in mouse models of narcolepsy. Sleep 32:111-116.
32. Shiromani PJ, Xu M, Winston EM, Shiromani SN, Gerashchenko D, Weaver DR (2004) Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. Am J Physiol Regul Integr Comp Physiol 287:R47-R57.
33. Siegel JM, Boehmer LN (2006) Narcolepsy and the hypocretin system- where motion meets emotion. Nat Clin Pract Neurol 2:548-556.
34. Siegel JM, Nienhuis R, Fahringer HM, Paul R, Shiromani P, Dement WC, Mignot E, Chiu C (1991) Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla. Science 252:1315-1318.
35. Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, Bennicelli JL, Rossi S, Marshall K, Banfi S, Surace EM, Sun J, Redmond TM, Zhu X, Shindler KS, Ying GS, Ziviello C, Acerra C, Wright JF, McDonnell JW, High KA, et al. (2010) Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 18:643-650.
36. Thankachan S, Kaur S, Shiromani PJ (2009) Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice. J Neurosci 29:1580-1585.
37. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-474.
38. van den Pol AN, Acuna-Goycolea C, Clark KR, Ghosh PK (2004) Physiological properties ofhypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 42:635-652.
39. Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, Leonard CS, Richardson JA, Hammer RE, Yanagisawa M (2003) Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice. Molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 38:715-730.
40. Wu MF, Gulyani SA, Yau E, Mignot E, Phan B, Siegel JM (1999) Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 91:1389-1399.